SIGNAL TRANSDUCTION INHIBITORS AS NOVEL ANTICANCER DRUGS - WHERE ARE WE

被引：11
|
作者：
WORKMAN, P
机构：
[1] Cancer Research Campaign Beatson Laboratories, CRC Department of Medical Oncology, University of Glasgow, Scotland
来源：
ANNALS OF ONCOLOGY | 1992年 / 3卷 / 07期
关键词：
D O I：
10.1093/oxfordjournals.annonc.a058253
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：527 / 531
页数：5
相关论文
共 50 条
  • [31] Signal transduction inhibitors from microorganisms
    Wrigley, SK
    Kau, DA
    Waters, B
    Davies, JE
    BIODIVERSITY: NEW LEADS FOR THE PHARMACEUTICAL AND AGROCHEMICAL INDUSTRIES, 2000, (257): : 86 - 99
  • [32] The use of signal transduction inhibitors with radiation
    McKenna, WG
    Bernhard, EJ
    Muschel, RJ
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S1 - S1
  • [33] Wavelet based signal processing: Where are we and where are we going?
    Burrus, CS
    DSP 97: 1997 13TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING PROCEEDINGS, VOLS 1 AND 2: SPECIAL SESSIONS, 1997, : 3 - 5
  • [34] Anticancer drugs: Redesigning kinase inhibitors
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (02)
  • [35] Histone Deacetylase Inhibitors as Anticancer Drugs
    Eckschlager, Tomas
    Plch, Johana
    Stiborova, Marie
    Hrabeta, Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [36] Peptidomimetics and metalloprotease inhibitors as anticancer drugs
    Li Su
    WenFang Xu
    Science in China Series B: Chemistry, 2009, 52 : 535 - 548
  • [37] Inhibitors of proteases as anticancer drugs -: Minireview
    Jedinák, A
    Maliar, T
    NEOPLASMA, 2005, 52 (03) : 185 - 192
  • [38] Peptidomimetics and metalloprotease inhibitors as anticancer drugs
    Su Li
    Xu WenFang
    SCIENCE IN CHINA SERIES B-CHEMISTRY, 2009, 52 (05): : 535 - 548
  • [39] The development of proteasome inhibitors as anticancer drugs
    Adams, J
    CANCER CELL, 2004, 5 (05) : 417 - 421
  • [40] Proteasome inhibitors as new anticancer drugs
    Adams, J
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (06) : 628 - 634
12345